Advertisement
Correspondence| Volume 46, ISSUE 12, P1711, December 15, 1999

Download started.

Ok

Reply

      Hamer and Simpson address several limitations in the analyses in our article, principally raising questions about the number of tests conducted and the possibility of a type 1 error. Bipolar disorder, especially rapid cycling, does pose difficulties in terms of establishing dependent variables and conducting statistical tests. Inherently, this is because improvement in index symptomatology, worsening of symptomatology, assessment of some measure of global severity of illness, and number and frequency of episodes are all fundamentally important. Further, changes can be principally captured as categorical improvement or mean change. Unlike a condition such as hypertension, a single measure cannot provide an adequate proxy for the multiple dimensional components of the disease. We have addressed these methodological issues in recent publications (
      • Bowden C.L.
      • Swann A.C.
      • Calabrese J.R.
      • McElroy S.L.
      • Morris D.
      • Petty F.
      • et al.
      Maintenance clinical trials in bipolar disorder Design implications of the divalproexlithium-placebo study.
      ,
      • Calabrese J.R.
      • Bowden C.L.
      • Sachs G.S.
      • Ascher J.A.
      • Monaghan E.
      • Rudd D.G.
      A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression.
      ). We tested three dependent measures. If a Bonferoni correction is applied, this would result in an α value of .017 as equivalent to a nominal .05. As we state, these tests were conducted at endpoint on the intent to treat sample, with last observation carried forward, not, as Hamer and Simpson suggest, on multiple time points.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bowden C.L.
        • Swann A.C.
        • Calabrese J.R.
        • McElroy S.L.
        • Morris D.
        • Petty F.
        • et al.
        Maintenance clinical trials in bipolar disorder.
        Psychopharmacol Bull. 1997; 33: 693-699
        • Calabrese J.R.
        • Bowden C.L.
        • Sachs G.S.
        • Ascher J.A.
        • Monaghan E.
        • Rudd D.G.
        A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression.
        J Clin Psychiatry. 1999; 60: 79-88